Hydralyte is the leading over-the-counter oral rehydration brand in Australia, and will be marketed and sold through Care Pharmaceuticals, Prestige’s subsidiary in Australia.
The transaction was finalised pursuant to the original terms of the purchase agreement announced on 15 April 2014.
As previously mentioned, the acquisition of Hydralyte is projected to double the revenues of Care to approximately AU $50m and is expected to be accretive to Prestige’s earnings per share for fiscal 2015, exclusive of transaction, integration and purchase accounting items.
Prestige acquired Care in July 2013.
Source: Prestige Brands Holdings
© FoodBev Media Ltd 2024